AIR Recon DL
A partial mapping of two reviewed FDA submissions. Evidence, compatible inputs, licensing and availability remain specific to each record.
The K252379 summary explicitly describes a modification of AIR Recon DL K213717. The phase-correction enhancement needs an additional software option key. Scanner-system records are not included.
Mapped FDA decisions, earliest first
Latest mapped does not mean latest sold or installed. Choose an exact FDA record before comparing.
- Related FDA recordAIR Recon DL (K213717)
AIR Recon DL in K213717
FDA decision: 2022-06-08 · record reviewed 2026-11-09 - Related FDA recordAIR Recon DL (K252379)
AIR Recon DL with Phase Correction in K252379
Latest mapped FDA decisionFDA decision: 2025-12-23 · record reviewed 2026-11-09
Documented names and scope
- AIR Recon DL · K213717. Name for this exact FDA record, not an alias for every commercial configuration. Name source
- AIR Recon DL with Phase Correction · K252379. Name for this exact FDA record, not an alias for every commercial configuration. Name source
AIR Recon DL
MR reconstruction to reduce noise and ringing artifacts. Applies to K213717, K252379. This describes the mapped function only; feature parity and a shared license are not established.
Availability evidence, separate from FDA decisions
- not established
Current availability of an exact FDA-submission configuration is not established. Ask the supplier for the offered release and licensed modules.
- Latest FDA decision among these records
- K252379 · 2025-12-23. Latest mapped decision only. Not automatically the latest sold or installed version, and not a supersession claim.
- Latest documented release
- Current commercial release or exact offered configuration is not established by this partial mapping.
- Current commercial availability
- Current commercial release or exact offered configuration is not established by this partial mapping.